Weight and Healthcare

While progress toward weight-neutrality is absolutely being made, our healthcare is predominantly based in the weight-centric paradigm. This paradigm currently considers simply existing in a higher-w…

Eil Lilly has recently announced that they are going to sell their weight loss drug, Zepbound, directly to consumers who can’t get insurance coverage and don’t qualify for other cost-lowering program…

I got this question from reader Jenn:

I was hate watching a workshop about “ob*sity” treatment and one of the people on the panel said that “ob*sity” isn’t a disease unless it impacts someone’s health…

In Part 1, by reader request, I began a discussion of the NBC news article “Weight loss drugs like Wegovy may trigger eating disorders in some patients, doctors warn”. Today we'll complete that discu…

Many of you asked me to write about the NBC News Article “Weight loss drugs like Wegovy may trigger eating disorders in some patients, doctors warn” by Liz Szabo, Marina Kopf and Akshay Syal, M.D.

This is the Weight and Healthcare newsletter! If you like what you are reading, please consider subscribing and/or sharing!

I received this question from reader Louise:

I see you and other people talk …

In part 1 we talked about a Medscape Today article that reader Antoni sent me about weight stigma in healthcare called “Weight Stigma is Bad Medicine.” The author, Mengyi (Zed) Zha, MD made important…

Reader Antoni sent me the following question.

I saw this article posted on LinkedIn (Weight Stigma is Bad Medicine by Mengyi (Zed) Zha, MD in MedPageToday). I feel like the author made good points but…

In part 1 we started looking at a company called PrescribeFit that is focused on getting referrals from orthopedics office of higher-weight patients with musculoskeletal (MSK) issues. We looked at th…

This came up in our monthly subscriber Ask Me Anything and then from another email from reader Julie who wrote:

“I hurt my knee playing soccer. After a lot of of imaging I was told it wasn’t surgical.…

Many of you have reached out asking me to write about Brandi Mallory and Mandisa Hundley’s deaths. Today is the day I’m going to do that. I want to start by saying that their deaths, regardless of ca…

I got the following question from reader Kyrie:

I started having pain in my knee after I jumped out of a truck and twisted it. I went to my regular doctor and he referred me to an orthopedist. He (the…

Reader Kellisa sent me the following question:I appreciate all the different things you write about, but some of my favorite newsletters are where you show how people and studies are paid for by the …

As I discuss the issues of GLP-1 agonist and GLP-1/GIP co-agonist weight loss drugs Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)I’ve been increasingly hearing from people who are …

This is the Weight and Healthcare newsletter! If you like what you are reading, please consider subscribing and/or sharing!

Reader Shauna asked “I just saw an article about the Body Roundness Index, i…

This came up in our monthly Subscriber Ask Me Anything discussion and it’s something I get asked about a lot – how can you advocate for a fat* friend/family member in a healthcare appointment?

The co-opting of concepts from weight-neutral health community to sell weight loss (or obfuscate the harm it causes) is rampant. We’ve talked about this with the concept of weight stigma and fake ant…

In my recent quick guide to creating a size-inclusive office, I mentioned troncoconical blood pressure cuffs and I heard from a number of people in healthcare who said that they had never heard of th…

In part 1 we talked about the research (or lack thereof) around the ways in which GLP-1 drugs, taken in large doses for weight loss, might impact the absorption of other medications. Today, we’re goi…

One of the questions I’ve been getting a lot is about how the new GLP-1 weight loss drugs (Novo’s Semaglutide Wegovy) and GLP-1/GIP co-agonist weight loss drugs (Lilly’s Tirzepatide/Zepbound) can int…